Bougerolle A M, Chabard J L, Dordain G, Frydman A, Gaillot J, Piron J J, Petit J, Berger J A
Eur J Drug Metab Pharmacokinet. 1986 Apr-Jun;11(2):113-8. doi: 10.1007/BF03189836.
The kinetics of metapramine and two of its demethylated metabolites were determined in six normal subjects after oral administration of a single 150 mg dose on day 1 and 3 X 50 mg dose on day 2-6. This study has shown that three demethylated metabolites are found in plasma beside metapramine. The monodemethylated metabolite I appeared to be the predominant one and the mean area under the plasma concentration curve (AUCo24) was 49% of the metapramine value. Its half-life was shorter (5.92 h) than that of metapramine (8.29 h). The kinetic profiles of metapramine and its major metabolites I and II were similar and data over 24 h could be fitted by a tri-exponential equation even though entero-hepatic cycles were observed. A high interindividual variability of data was found for both metapramine and its metabolites. There were no significant differences between men and women. The minimal plasma level (Cmin) seemed in agreement with the half-life of the drug.
在6名正常受试者中,于第1天口服单次150 mg剂量,第2 - 6天口服3次50 mg剂量后,测定了间普拉明及其两种去甲基代谢物的动力学。该研究表明,除间普拉明外,血浆中还发现了三种去甲基代谢物。单去甲基代谢物I似乎是主要的代谢物,血浆浓度曲线下平均面积(AUCo24)为间普拉明值的49%。其半衰期(5.92小时)比间普拉明的半衰期(8.29小时)短。间普拉明及其主要代谢物I和II的动力学特征相似,即使观察到肠肝循环,24小时的数据也可用三指数方程拟合。间普拉明及其代谢物的数据均存在较高的个体间变异性。男性和女性之间无显著差异。最低血浆水平(Cmin)似乎与药物的半衰期一致。